K.I.D.S. IQ Project is an international non-profit foundation focused on the advancement of drug treatments for reversible Intellectual Disability (ID) disorders, specifically those arising from a gene deletion or mutation. Their initial focus is on Kleefstra syndrome (KS) and related ID disorders that have a potentially synergistic approach to drug development. Such related ID disorders include:
ID disorders such as KS, resulting from deletions or mutations in genes encoding or interacting with components of the epigenetic machinery. These epigenetic genes play an important role in turning other genes “on” or “off,” both at the right time and in the right place within the human body. Learn more about epigenetics
Genetic disorders on the Autism Spectrum that also result in ID (this group represents a significant percentage of Autism Spectrum Disorder patients); KS patients, much like many other genetic disorder patient groups, commonly exhibit autistic-like features alongside ID
Other such ID disorder groups that may arise through scientific understanding
K.I.D.S. IQ Project also aims to enhance the quality of life for those living with such ID disorders and their associated health issues by providing important educational information, programs and services.